Ronco’s Global Pharmaceutical Experience Will Support the Next Chapter of Emmes’ Growth and Technology Enablement
 

Rockville, MD, September 20, 2023 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.

Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development.
 

A Technology Catalyst Enabling Innovative Clinical Research, Essex Enriches and Complements Emmes’ Services
 

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of Essex Management.  Essex offers bioinformatics and health information technology (HIT) consulting services to government, private sector and academic organizations.
 

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the opening of a new office in Wilmington, North Carolina.
 

According to Emmes Chief Executive Officer Dr. Christine Dingivan, “Wilmington is a center for clinical research innovation, and creating this new office will encourage even more collaboration and idea-sharing among our employees in the area. We are thrilled to expand our presence in a community viewed as an incubator for the CRO industry.”

Mergers & Acquisitions (M&A) Expertise Adds Value to Emmes’ Growth  Plans

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Matt Honan has joined the company as vice president and global head of corporate development.

New COO Adds International Experience and Clinical Operations Depth to Emmes’ Portfolio
 

Rockville, MD, December 15, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Wendy Buckland will join the company as its chief operating officer, leading global operations.

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Ching Tian has joined the company as chief innovation officer.
 

Decades of Experience and Emerging Opportunities Led to its Creation.
 

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.

Global CRO’s India office reports surging growth from Western, regional and local trial customers
 

VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of VaxTRIALS. Headquartered in Panama City, Panama, VaxTRIALS’ 160+ staff members manage and monitor vaccine clinical trial activities throughout Latin America.